Search by Drug Name or NDC
NDC 00527-1396-10 Loxapine 25 mg/1 Details
Loxapine 25 mg/1
Loxapine is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Lannett Company, Inc.. The primary component is LOXAPINE SUCCINATE.
MedlinePlus Drug Summary
Loxapine is used to treat the symptoms of schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions). Loxapine is in a group of medications called conventional antipsychotics. It works by decreasing abnormal excitement in the brain.
Related Packages: 00527-1396-10Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Loxapine
Product Information
| NDC | 00527-1396 |
|---|---|
| Product ID | 0527-1396_d3cf2be5-8c99-4a5a-85ec-be5aa26ac928 |
| Associated GPIs | 59154020200115 |
| GCN Sequence Number | 003982 |
| GCN Sequence Number Description | loxapine succinate CAPSULE 25 MG ORAL |
| HIC3 | H7U |
| HIC3 Description | ANTIPSYCHOTICS, DOPAMINE AND SEROTONIN ANTAGONISTS |
| GCN | 15561 |
| HICL Sequence Number | 001664 |
| HICL Sequence Number Description | LOXAPINE SUCCINATE |
| Brand/Generic | Generic |
| Proprietary Name | Loxapine |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Loxapine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 25 |
| Active Ingredient Units | mg/1 |
| Substance Name | LOXAPINE SUCCINATE |
| Labeler Name | Lannett Company, Inc. |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA090695 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00527-1396-10 (00527139610)
| NDC Package Code | 0527-1396-10 |
|---|---|
| Billing NDC | 00527139610 |
| Package | 1000 CAPSULE in 1 BOTTLE, PLASTIC (0527-1396-10) |
| Marketing Start Date | 2011-09-26 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |